ViralClear Publishes in F1000 Research In Vitro Data Demonstrating Synergy between Merimepodib and Remdesivir Against SARS CoV 2, the Cause of COVID 19

Press/Media: Expert Comment

PeriodMay 14 2020

Media coverage

2

Media coverage